Alcon Stock (NYSE:ALC)


ForecastOwnershipChartTranscripts

Previous Close

$66.11

52W Range

$61.84 - $92.55

50D Avg

$70.90

200D Avg

$76.42

Market Cap

$32.42B

Avg Vol (3M)

$1.92M

Beta

0.70

Div Yield

$0.36 (0.54%)

ALC Company Profile


Alcon Inc. is a global leader in eye care, engaging in the comprehensive lifecycle of ophthalmic solutions, from initial research and development to manufacturing, distribution, and worldwide sales. Its diverse portfolio serves both eye care professionals and the patients they treat across the globe. The company's operations are divided into two main segments: 1. Surgical Segment: This division provides a vast array of products crucial for ophthalmic surgical procedures. Offerings encompass advanced equipment, sophisticated diagnostic tools, and implantable devices such as intraocular lenses (IOLs). It also supplies essential consumables, including viscoelastics, specialized surgical solutions, incisional instruments, and custom surgical procedure packs. Key product areas within this segment feature: Cataract Management: Technologies like the Centurion Vision System, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and the ORA system for intra-operative measurements, along with custom pak surgical procedure kits. Vitreoretinal Interventions: Including Constellation Vision Systems, procedure packs, lasers, hand-held microsurgical instruments (such as grieshaber and MIVS), a range of scissors, forceps, micro-instruments, medical-grade vitreous tamponades, and Hypervit vitrectomy probes. Refractive Correction: WaveLight lasers and Contoura Vision, specifically utilized for LASIK treatments. Glaucoma Solutions: The EX-PRESS glaucoma filtration device. Advanced Implantables: Such as AcrySof IQ IOLs, which include both monofocal IOLs and cutting-edge technology IOLs marketed under the PanOptix and ReSTOR brands, designed to correct presbyopia and astigmatism during cataract surgery. 2. Vision Care Segment: This segment delivers products aimed at daily vision needs and overall ocular health. Its offerings include daily disposable, reusable, and color-enhancing contact lenses. Furthermore, it provides a variety of eye health products addressing issues like dry eye, glaucoma, contact lens maintenance, and ocular allergies, alongside eye vitamins and redness relievers. These are available under prominent brands such as TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux. Established in 1945, Alcon Inc. changed its name from Alcon Universal S.A. to its current designation in December 2001. The company's corporate headquarters are located in Geneva, Switzerland.

Show More

Industry

Medical - Instruments & Supplies

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

CH

Employees

25,599

IPO Date

Apr 09, 2019

Website

ALC Performance


Latest Earnings Call Transcripts


Q1 26May 06, 26 | 12:00 AM
Q4 25Feb 25, 26 | 8:00 AM
Q3 25Nov 12, 25 | 8:00 AM

Peer Comparison


TickerCompany
RMDResMed Inc.
MTDMettler-Toledo International Inc.
HUMHumana Inc.
CAHCardinal Health, Inc.
INSMInsmed Incorporated
BDXBecton, Dickinson and Company
IQVIQVIA Holdings Inc.
AAgilent Technologies, Inc.
WSTWest Pharmaceutical Services, Inc.
GEHCGE HealthCare Technologies Inc.